HAYWARD, Calif.--(BUSINESS WIRE)--March 14, 2007--IMPAX
Laboratories, Inc. (OTC:IPXL) today announced that Arthur A. Koch,
Jr., its senior vice president and chief financial officer, will
present at the Lehman Brothers 10th Annual Global Healthcare
Conference on Tuesday, March 20th, from 4:15 p.m. to 4:40 p.m. Eastern
Time. The conference will be held at the Loews Miami Beach Hotel in
Miami, Florida from March 19 to 21, 2007.
Individuals may listen to the live or an archived version of the
presentation made at the conference, which will be posted in the
investor relations section of the Company's web site at
www.impaxlabs.com. To listen to the live presentation, please go to
the web site 15 minutes prior to its start to register, download, and
install the necessary audio software. This presentation will be
archived on the Company's web site for 90 days. The Company's regular
Corporate presentation will be updated and posted on the Company's web
site on that date as well.
About IMPAX Laboratories, Inc.
IMPAX Laboratories, Inc. is a technology based specialty
pharmaceutical company applying its formulation expertise and drug
delivery technology to the development of controlled-release and
specialty generics in addition to the development of branded products.
IMPAX markets its generic products through its Global Pharmaceuticals
division and markets its branded products through the IMPAX
Pharmaceuticals division. Additionally, where strategically
appropriate, IMPAX has developed marketing partnerships to fully
leverage its technology platform. IMPAX Laboratories is headquartered
in Hayward, California, and has a full range of capabilities in its
Hayward and Philadelphia facilities. For more information, please
visit the Company's Web site at: www.impaxlabs.com.
CONTACT: IMPAX Laboratories, Inc.
Larry Hsu, Ph.D., 510-476-2000, x1111
President & CEO
or
Arthur A. Koch, Jr., 215-933-0351
Sr. VP & CFO
www.impaxlabs.com
or
Investor Relations Contacts:
Lippert/Heilshorn & Associates, Inc.
Kim Sutton Golodetz, 212-838-3777
kgolodetz@lhai.com
or
Bruce Voss, 310-691-7100
bvoss@lhai.com
www.lhai.com
SOURCE: IMPAX Laboratories, Inc.